Submit Deal

AVORO CAPITAL

Summary

Avoro Capital is a global life sciences investment firm with a focus on supporting emerging biotechnology companies.

Deals Overview

Total Deals4

Valued Deals3

Total Value£ 482 M

Avg. Deal Size£ 161 M

Market Context

Senior Management

Behzad Aghazadeh
Managing Partner
Uya Chuluunbaatar
Partner

Sort

13 Jan 2021|Denmark|Biotechnology

Target: IO BIOTECH

Bidder: LUNDBECKFONDEN EMERGE

16 Service Providers

2 Target | 14 Bidder

16 Dealmakers

2 Target | 14 Bidder

£ 113 M

Value

14 Apr 2021|United States|Biotechnology

Target: TANGO THERAPEUTICS

Bidder: CORMORANT ASSET MANAGEMENT

29 Service Providers

5 Target | 24 Bidder

32 Dealmakers

15 Target | 19 Bidder

£ 257 M

Value

17 May 2021|United States|Pharmaceuticals

Target: AADI BIOSCIENCE INC

Bidder: AERPIO PHARMACEUTICALS INC

22 Service Providers

4 Target | 18 Bidder

44 Dealmakers

23 Target | 21 Bidder

n/a

Value

21 Feb 2023|Denmark|Biotechnology

Target: HEMAB

Bidder: MAJ INVEST EQUITY A/S

10 Service Providers

1 Target | 9 Bidder

13 Dealmakers

2 Target | 11 Bidder

£ 111 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy